Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 129

Cited In for PubMed (Select 20065329)

1.

Azolylthioacetamide: A Highly Promising Scaffold for the Development of Metallo-β-lactamase Inhibitors.

Yang SK, Kang JS, Oelschlaeger P, Yang KW.

ACS Med Chem Lett. 2015 Feb 12;6(4):455-60. doi: 10.1021/ml500534c. eCollection 2015 Apr 9.

PMID:
25893049
2.

Factors That Affect Transfer of the IncI1 β-Lactam Resistance Plasmid pESBL-283 between E. coli Strains.

Händel N, Otte S, Jonker M, Brul S, Ter Kuile BH.

PLoS One. 2015 Apr 1;10(4):e0123039. doi: 10.1371/journal.pone.0123039. eCollection 2015.

3.

Antibacterial properties and atomic resolution X-ray complex crystal structure of a ruthenocene conjugated β-lactam antibiotic.

Lewandowski EM, Skiba J, Torelli NJ, Rajnisz A, Solecka J, Kowalski K, Chen Y.

Chem Commun (Camb). 2015 Mar 24;51(28):6186-9. doi: 10.1039/c5cc00904a.

PMID:
25753149
4.

Computer aided screening of potent inhibitor compounds against inhibitor resistant TEM β-lactamase mutants from traditional Chinese medicine.

Zhu Q, Yin Y, Liu H, Tian J.

Bioinformation. 2014 Dec 31;10(12):750-6. doi: 10.6026/97320630010750. eCollection 2014.

5.

Detecting a quasi-stable imine species on the reaction pathway of SHV-1 β-lactamase and 6β-(hydroxymethyl)penicillanic acid sulfone.

Che T, Rodkey EA, Bethel CR, Shanmugam S, Ding Z, Pusztai-Carey M, Nottingham M, Chai W, Buynak JD, Bonomo RA, van den Akker F, Carey PR.

Biochemistry. 2015 Jan 27;54(3):734-43. doi: 10.1021/bi501197t. Epub 2015 Jan 8.

PMID:
25536850
6.
7.

Combinatorial active-site variants confer sustained clavulanate resistance in BlaC β-lactamase from Mycobacterium tuberculosis.

Egesborg P, Carlettini H, Volpato JP, Doucet N.

Protein Sci. 2015 Apr;24(4):534-44. doi: 10.1002/pro.2617. Epub 2014 Dec 30.

PMID:
25492589
8.

Insight into the effect of inhibitor resistant S130G mutant on physico-chemical properties of SHV type beta-lactamase: a molecular dynamics study.

Baig MH, Sudhakar DR, Kalaiarasan P, Subbarao N, Wadhawa G, Lohani M, Khan MK, Khan AU.

PLoS One. 2014 Dec 5;9(12):e112456. doi: 10.1371/journal.pone.0112456. eCollection 2014.

9.

Unexpected challenges in treating multidrug-resistant Gram-negative bacteria: resistance to ceftazidime-avibactam in archived isolates of Pseudomonas aeruginosa.

Winkler ML, Papp-Wallace KM, Hujer AM, Domitrovic TN, Hujer KM, Hurless KN, Tuohy M, Hall G, Bonomo RA.

Antimicrob Agents Chemother. 2015 Feb;59(2):1020-9. doi: 10.1128/AAC.04238-14. Epub 2014 Dec 1.

PMID:
25451057
10.

Biochemical and structural analysis of inhibitors targeting the ADC-7 cephalosporinase of Acinetobacter baumannii.

Powers RA, Swanson HC, Taracila MA, Florek NW, Romagnoli C, Caselli E, Prati F, Bonomo RA, Wallar BJ.

Biochemistry. 2014 Dec 9;53(48):7670-9. doi: 10.1021/bi500887n. Epub 2014 Nov 25.

PMID:
25380506
11.

Biochemical characterization of New Delhi metallo-β-lactamase variants reveals differences in protein stability.

Makena A, Brem J, Pfeffer I, Geffen RE, Wilkins SE, Tarhonskaya H, Flashman E, Phee LM, Wareham DW, Schofield CJ.

J Antimicrob Chemother. 2015 Feb;70(2):463-9. doi: 10.1093/jac/dku403. Epub 2014 Oct 16.

12.

Enantioselective Synthesis and Profiling of Two Novel Diazabicyclooctanone β-Lactamase Inhibitors.

Xiong H, Chen B, Durand-Réville TF, Joubran C, Alelyunas YW, Wu D, Huynh H.

ACS Med Chem Lett. 2014 Aug 12;5(10):1143-7. doi: 10.1021/ml500284k. eCollection 2014 Oct 9.

PMID:
25313328
13.

Mechanism of Orlistat Hydrolysis by the Thioesterase of Human Fatty Acid Synthase.

Fako VE, Zhang JT, Liu JY.

ACS Catal. 2014 Oct 3;4(10):3444-3453. Epub 2014 Aug 21.

PMID:
25309810
14.

Application of cyclic phosphonamide reagents in the total synthesis of natural products and biologically active molecules.

Focken T, Hanessian S.

Beilstein J Org Chem. 2014 Aug 13;10:1848-77. doi: 10.3762/bjoc.10.195. eCollection 2014. Review.

15.

The tandem repeats enabling reversible switching between the two phases of β-lactamase substrate spectrum.

Yi H, Song H, Hwang J, Kim K, Nierman WC, Kim HS.

PLoS Genet. 2014 Sep 18;10(9):e1004640. doi: 10.1371/journal.pgen.1004640. eCollection 2014 Sep.

16.

Alkylidene Oxapenem β-Lactamase Inhibitors Revisited: Potent Broad Spectrum Activity but New Stability Challenges.

Miller MD, Kale M, Reddy K, Tentarelli S, Zambrowski M, Zhang M, Palmer T, Breen J, Lahiri S, Shirude PS, Verheijen JC.

ACS Med Chem Lett. 2014 Jun 20;5(8):915-20. doi: 10.1021/ml5001855. eCollection 2014 Aug 14.

PMID:
25147614
17.

Integrating forecast probabilities in antibiograms: a way to guide antimicrobial prescriptions more reliably?

Maurer FP, Courvalin P, Böttger EC, Hombach M.

J Clin Microbiol. 2014 Oct;52(10):3674-84. doi: 10.1128/JCM.01645-14. Epub 2014 Aug 6.

18.

New trends in aminoglycosides use.

Fosso MY, Li Y, Garneau-Tsodikova S.

Medchemcomm. 2014 Aug 1;5(8):1075-1091.

PMID:
25071928
19.

Deletion mutations conferring substrate spectrum extension in the class A β-lactamase.

Hwang J, Cho KH, Song H, Yi H, Kim HS.

Antimicrob Agents Chemother. 2014 Oct;58(10):6265-9. doi: 10.1128/AAC.02648-14. Epub 2014 Jul 21.

20.

Protein variants form a system of networks: microdiversity of IMP metallo-beta-lactamases.

Widmann M, Pleiss J.

PLoS One. 2014 Jul 11;9(7):e101813. doi: 10.1371/journal.pone.0101813. eCollection 2014.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk